Minichromosome maintenance proteins (Mcm's) are components of the DNA replication licensing complex. In vivo, reduced expression or activity of Mcm's has been shown to result in highly penetrant early onset cancers (Shima et al., 2007; Pruitt et al., 2007) and stem cell deficiencies (Pruitt et al., 2007) . Here we use mouse embryonic fibroblasts from an Mcm2-deficient strain of mice to show by DNA fiber analysis that origin usage is decreased in Mcm2-deficient cells under conditions of hydroxyurea (HU)-mediated replication stress. DNA damage responses (DDRs) resulting from HU and additional replication-dependent and replication-independent genotoxic agents were also examined and shown to function at wild-type (wt) levels. Further, basal levels of many components of the DDR were expressed at wt levels, showing that there is no acute replicative stress under normal growth conditions. Only very modest, 1.5-to 2-fold increases in the basal levels of c-H2AX, p21 cip1 and 53bp foci were found, consistent with a slight chronic elevation in DDR pathways. The one condition in which a larger difference between wt-and Mcm2-deficient cells was found occurred after ultraviolet irradiation and may reflect the role of Chk1-mediated suppression of dormant origins. In vivo, abrogating p53-mediated DDR in Mcm2-deficient mice results in increased embryonic lethality and accelerated cancer formation in surviving mice. Further, p53 mutation rescues the negative effect of Mcm2 deficiency on the survival of neural stem cells in vitro; however, the enhanced survival correlates with increased genetic damage relative to Mcm2 wt cells carrying the p53 mutation. Together these results show that even relatively minor perturbations to primary or dormant replication origin usage contribute to accelerated genetic damage in vivo. In addition, these studies show that tumor types resulting from Mcm2 deficiency are strongly affected by interaction with both genetic background and p53.
Introduction
It has been hypothesized that the accumulation of genetic damage in somatic stem cells results in both agerelated tissue decline and cancer. Much of the support for this hypothesis is derived from mouse models, where it has been shown that there is high degree of overlap in the genes that affect the rate of aging generally and the rate of cancer incidence. Specifically, studies of mutations in the genes responsible for mediating cell-cycle arrest after DNA damage and repairing damaged DNA suggest that common mechanisms affect both processes (Lombard et al., 2005; Rossi et al., 2008) . It has further been suggested that, in mammals, the target for this damage is somatic stem cells because, although such damage can be eliminated from the differentiated components of a replenishing tissue, genetic damage within the stem cell is permanent.
The mechanisms leading to genetic damage initially have been less well-defined and may have multiple causes. However, one potential source that is likely to have a significant role in organisms such as mammals, which depend heavily on tissue replacement, is errors occurring during DNA replication. This hypothesis is supported by the phenotypes of two lines of mice, Mcm4
Chaos3 and Mcm2
IresCreERT2
, each of which carry an allele of a component of the DNA replication machinery resulting in hypomorphic or deficient expression (Pruitt et al., 2007; Shima et al., 2007) . In each case, the mice carrying these alleles exhibit an elevated rate of cancer incidence.
Mcm's (minichromosome maintenance proteins) consist of a family of six proteins (Mcm2-7), which are components of the DNA replication licensing complex that binds to origins of replication early in the G1 phase of the cell cycle (reviewed by Blow and Dutta (2005) , Forsburg (2004) , Lei (2005) , Tye (1999) ). This complex is required for initiation of DNA replication during the subsequent S phase but is displaced from origins on initiation of replication; hence, one role of the Mcm's is to prevent multiple rounds of replication from a single origin and suppression of endoreduplication. One consequence of reduced Mcm activity or concentration could then be a reduction in the number of origins that are used during S phase. Many more origins are licensed during G1 phase than are normally initiated during S phase (reviewed by Hyrien et al. (2003) ). However, when the movement of replication forks is inhibited, initiation occurs at otherwise dormant origins. Initiation from these origins is thought to help ensure that S phase is completed. Consistent with this role, studies using smallinterfering RNA-mediated suppression of Mcm's in conjunction with DNA fiber analysis have shown that it is possible to reduce the number of Mcm's loaded onto DNA to levels that do not impair DNA replication under normal growth conditions but which result in reduced dormant origin usage under conditions of replicative stress (Ge et al., 2007; Ibarra et al., 2008) . Finally, Mcm's have been implicated as mediators of the DNA damage response (DDR) when the replisome encounters a genetic lesion (Cortez et al., 2004) . These multiple roles of the Mcm's complicate the interpretation of the phenotypes of Mcm hypomorphic or deficient mice.
Here we have examined the effect of the Mcm2
IresCreERT2 allele (referred to as Mcm2 def in this report), which is known to result in expression of Mcm2 at a level that is B1/3 of wild type (wt), on the DDR in mouse embryonic fibroblasts (MEFs) in vitro and the interaction of this Mcm deficiency allele with a p53 null allele by genetic crosses in vivo.
Results

DNA fiber analysis confirms reduced dormant origin usage in Mcm2-deficient MEFs
Previous studies using small-interfering RNA to suppress expression of various Mcm's have shown, by DNA fiber analysis, that origin usage is suppressed under conditions of replicative stress (Ge et al., 2007; Ibarra et al., 2008) . Here, we have used fiber analysis of MEFs, pulsed with chlorodeoxyuridine (CldU) followed by iododeoxyuridine (IdU), to determine if a similar reduction in origin usage is observed in genetically modified Mcm2-deficient cells in the presence of hydroxyurea (HU). Figure 1a shows an example of a doublelabeled fiber. Figure 1b shows that the interorigin distance is not significantly different in untreated Mcm2 wt and Mcm2 def MEFs (59.2 kb, s.e.m. ± 5.5, and 58.5 kb, s.e.m.±2.0, respectively; P ¼ 0.85). In contrast, after treatment with 200 mM HU, the inter-origin distance in wt cells decreases significantly to 42.0 kb (s.e.m. ± 1.6, P ¼ 3.9 Â 10 À6 relative to wt no HU), whereas HUtreated Mcm2 def cells show a minimal decrease to 56.1 kb (s.e.m. ± 2.4, P ¼ 0.42, relative to Mcm2 def no HU). These observations confirm that replication stress results in recruitment of dormant origins in wt cells and that this recruitment is compromised in Mcm2-deficient cells.
DDR in Mcm2-deficient cells in vitro
Previous studies have suggested that the failure to initiate DNA replication from primary or dormant origins causes an increase in basal levels of genetic damage (Pruitt et al., 2007; Ge et al., 2007; Ibarra et al., 2008) . Alternatively, Mcm's may have a role in mediating the DDR leading to an inefficient response to any source of genetic damage (reviewed by Forsburg (2004) def line of mice. The enhanced response of Mcm2-deficient cells to UV (elevated pChk1, total p53 and G1 arrest) may reflect a specific role of Chk1 in suppressing the activity of dormant origin usage (Ge et al., 2007; Ibarra et al., 2008) .
These studies also show that the basal levels of components of the DDR are also largely unaffected. Only a marginal increase (B1.5 Â ) in the basal levels of p21, and in some experiments g-H2AX, is observed in untreated Mcm2-deficient relative to wt cells. A small increase, B1.5-fold, of 53bp foci was also seen in untreated Mcm2-deficient cells (Supplementary Information) , which is consistent with the previous observation of an B1.5-fold increase in g-H2AX foci in satellite cells derived from Mcm2-deficient mice (Pruitt et al., 2007) . These observations are consistent with marginal elevation in the DDR in Mcm2-deficient cells that could reflect a small constitutive elevation in the rate of genetic damage in these cells. 
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Survival of mice of all of the different genotypes is shown in Figure 5a and subsets of these data are shown in Figures 5b and c. Figure 5b shows mice that are homozygous for the Mcm2 deficiency allele but carry different levels of p53, and shows that the absence of the p53-mediated DDR further accelerates the already early lethality observed Mcm2 def/def mice in the presence of wt p53 activity. There is, however, no apparent effect of p53 dosage because mice that are wt or heterozygous for the p53 null allele show similar longevity. Figure p53 mutation rescues neurosphere growth Previous studies of Mcm2 def/def mice have shown that neural stem or progenitor cells are reduced relative to wild animals by both in situ analyses of the subventrical zone and clonogenic neurosphere assays (Pruitt et al., 2007) . One explanation for this effect is that it is a secondary consequence of the DDR to elevated levels of genetic damage in Mcm2-deficient mice. To test this idea, we sought to determine if the absence of a p53-mediated DDR would allow rescue of neural stem or progenitor cells in Mcm2 def/def mice. However, Mcm2 def/def : p53 null/null mice are rare and when they occur, they die due to tumors at very early times and before the point at which Mcm2 def/def mice exhibit a reduction in neurogenesis wt/null Â same mice were determined, and the proportion of mice with the indicated genotypes, relative to the expected number, is plotted as indicated in the figure. def/def E14.5 embryos and assessed in a clonogenic assay on day 10 of culture (Maslov et al., , 2007 , showed that the number and size of neurospheres recovered at this stage was similar. However, by 20 days in vitro with refeeding but without passaging, the proportion of the initial cultures that survived was reduced relative to wt in neurospheres was dependent on p53, except that beginning at day 10 of culture cells were passaged in the ratio of 1:2 every 2-3 days. As previously, no difference in the recovery or size of neurospheres was apparent at day 10. Survival of individual cultures with additional passaging is shown in Figure 6 . Results from this experiment confirm that Mcm2 deficiency results in reduced ability of neurospheres to regrow following passage in the context of wt p53 activity. However, neurospheres carrying the p53 null mutation show no reduction in their ability to passage, and show improved survival over p53 wt neurospheres, even when Mcm2 is deficient.
To directly measure the effect of Mcm2 deficiency on the accumulation of genetic damage, we have assessed loss of heterozygosity (LOH) at a variety of Mit markers in neurospheres derived from embryos of each of the four genotypes described above (Figure 6c) 
Interaction of Mcm2 deficiency and genetic background
The mixed genetic background of mice resulting from the backcross described above has allowed an assessment of the effects of genetic background on the phenotype resulting from Mcm2 deficiency in comparison to the effects of this allele on the pure 129Sv background on which it was originally derived.
Mcm2
wt/wt , Mcm2 wt/def and Mcm2 def/def mice on the 129Sv background have now been followed for 100 weeks. Previous studies have shown that Mcm2 def/def mice on the 129Sv background are short-lived with a median lifespan of only B12 weeks (Pruitt et al., 2007) . A similar value of B15 weeks was observed here for a slightly larger cohort. Further 100% of these mice exhibit thymomas on necropsy, although additional secondary polyps in the small intestine or colon and enlarged spleens are observed in a subset of these mice. The survival of Mcm2 def/def ;p53 wt/wt mice on a mixed 129Sv:BALB/c background is shown in comparison to that of Mcm2 def/def mice on the 129Sv background in Figure 7 . Initially, the survival of Mcm2 def/def mice on the mixed genetic background tracks with that of the 129Sv background such that by 15 weeks, half of the mice on each genetic background have died. However, for mice that survive beyond 15 weeks, there is a substantial difference in longevity where mice on a mixed genetic background have substantially longer life spans.
Tumorigenesis is also affected by background (Table 1) . Mcm2 deficiency on the 129Sv genetic background results in a remarkably high specificity and penetrance of tumor formation where all of the Mcm2 def/def mice on this background in a previous study (Pruitt et al., 2007) and in this study died due to ;p53 wt/wt mice of mixed 129Sv:BALB/c genetic background revealed that only 3 of 10 of these mice exhibited thymomas. Spleen involvement without evidence of thymoma was found in three additional mice. Although spleen is a site where tumors have been found on the 129Sv genetic background, these were always observed in mice in which the primary cause of morbidity was thymoma. Three liver tumors and one lung tumor were also observed on the mixed genetic background, which are sites at which tumors have not been found on the 129Sv background.
Tumor spectrum is also affected by the interaction of Mcm2 deficiency and loss or reduction of p53 activity.
A variety of tumors that have not been observed in mice carrying either mutant Mcm2 or p53 alleles alone are found in mice carrying at least one mutant allele in both genes.
Discussion
Mcm deficiencies on defined genetic backgrounds result in increased cancer incidence where the tumors show a high degree of penetrance and remarkable specificity in the types that are formed. Mcm4 deficiency resulting from the Chaos3 allele yields a 480% penetrance of mammary adenocarcinomas with a mean latency of 12 months in female C3H:Mcm4
Chaos3/Chaos3 mice (Shima et al., 2007) . In the case of the Mcm2 deficiency allele studied here and previously (Pruitt et al., 2007) , there is a 100% penetrance of thymoma in 129Sv:Mcm2 def/def affecting both males and females with a mean latency of less than 4 months. It is clearly important to understand the mechanisms by which Mcm deficiencies enhance tumorigenesis and result in profound bias toward specific tumor types in these animals.
In vitro studies have identified several potential mechanisms by which deficiencies in Mcm's could result in genetic damage. In different studies, Mcm levels were suppressed in human cell lines, to between nearly undetectable through B25% of wt, through RNA interference. Severe reduction of Mcm7 or Mcm2 has been shown to impair entry into G1 phase mediated by (Ibarra et al., 2008) . Nonetheless, cells grown under these conditions are hypersensitive to genotoxic agents, exhibit an enhanced DDR, accumulate genetic lesions and, over a period of B5 days, activate a checkpoint response that prevents continued division (Ibarra et al., 2008) . Somewhat less severe reduction in Mcm levels to B25% of wt (Ge et al., 2007) , similar to the level of Mcm2 expression in the Mcm2 def/def MEFs used here, allows more prolonged cell proliferation and alleviates much of the hypersensitivity to genotoxic agents. However, studies by both Ibarra et al. (2008) and Ge et al. (2007) show that, although origin usage in the absence of agents that induce replication fork arrest is similar between Mcm knockdown and control cells, in the presence of such agents the Mcm knockdown cells exhibited a greatly reduced ability to reinitiate DNA replication through the recruitment of dormant origins.
Here we show, by DNA fiber analysis, that MEFs derived from Mcm2-deficient mice exhibit a reduction in secondary origin usage under conditions of HU-induced replication stress, similar to the results of Ge et al. (2007) and Ibarra et al. (2008) . Further, Mcm2 def/def MEFs show little difference from wt cells in their DDR after treatment with genotoxic agents that act independently of replication (g-irradiation) or to agents that depend on replication to generate genetic damage (CPT, HU).
Although the DDR is intact in Mcm2-deficient cells, basal levels of g-H2AX and p21, and the frequency of 53bp foci, are marginally elevated in Mcm2 def/def cells in the absence of genotoxic agents. One explanation for these observations is that Mcm2 def/def cells have a slightly higher, but chronic, intrinsic rate of genomic damage relative to wt.
The major difference in DDR between wt and Mcm2-deficient cells observed here occurs after UV irradiation. These differences include elevated phosphorylation of Chk1 (at 2 h after treatment), elevated total p53 (at 8 h after treatment) and enhanced G1 arrest (at 7 h after treatment) where the G1 arrest is shown to be Mcm2 dose dependent. It is unlikely that this UV-induced response is a direct result of slightly elevated basal levels of genetic damage. Rather, it may reflect an interaction between ATR, Chk1 and Mcm's that is involved in mediating dormant origin usage. Previous studies have shown that dormant origin usage is suppressed by p-Chk1 under conditions of wt levels of Mcm's (Ge et al., 2007; Ibarra et al., 2008) . Further, UV irradiation is known to result in ATR-dependent phosphorylation of Chk1 (Heffernan et al., 2007) . The observations presented here suggest that availability of Chk1 for ATR-mediated phosphorylation is constrained by the level of Mcm's, such that reduced Mcm concentration results in a hyperactivation of Chk1 after UV treatment. We speculate that suppression of Chk1 phosphorylation by chromatin-bound Mcm's could have a role during S-phase progression. Early in S phase stalled replication forks may be overcome by initiation at dormant origins and a robust DDR and cell-cycle arrest is unwarranted. Suppression of Chk1 phosphorylation by Mcm's bound at dormant origins during early S phase would result in dampening of Chk1-mediated cell-cycle arrest. In contrast, late in S phase the ability to overcome a stalled replication fork through initiating replication at an adjacent origin may become progressively more limited, requiring a more robust checkpoint response. Loss of chromatin-bound Mcm's as replication proceeds would then facilitate Chk1 phosphorylation. Consistent with this role, the phosphorylation of Chk1 in response to UV in yeast is cell-cycle dependent, increasing as cells progress through S phase (Martinho et al., 1998; Miao et al., 2003) .
Despite (Pruitt et al., 2007; Shima et al., 2007) . These studies show that this specificity is not a result of Mcm2 deficiency per se but, rather, is tightly linked to genetic background. These observations are consistent with the finding that mice carrying the Mcm4
Chaos3 mutation show non-mammary adenocarcinoma tumor types on mixed genetic backgrounds (Shima et al., 2007) . It is likely that polymorphisms in genes that affect the outcome of Mcm-deficiency-mediated genetic damage contribute to whether tumors will ultimately occur. This study provides support for this possibility in that some effect of p53 status on tumor type is observed. The expanded spectrum of tumors occurring on Mcm2 def/def ;p53 wt/wt mice on a mixed 129/Sv:BALB/c genetic background, relative to the same genotype on a straight 129/Sv genetic background could similarly reflect polymorphisms in genes that determine the outcome of Mcm2-deficiencymediated genetic damage. Nonetheless, polymorphic function of such genes seems unlikely to account for the remarkable specificity of tumor type on specific genetic backgrounds.
An explanation that can account for both the high penetrance of specific tumor types on defined genetic backgrounds, and the observation that this specificity is dependent on genetic background, is suggested by the effect of Mcm deficiency on the activity of primary or dormant origins. Because all potential origins in a cell are in competition for binding of components of the replication machinery, under conditions where this machinery is limiting the specific subset of origins with the weakest affinity for these components will be preferentially affected. These 'weakest links' would then be expected to present sites at which damage is more likely to occur due to increased distance between origins or the inability to recovery from replication fork failure. Although replication origins are likely to be even more polymorphic than coding sequences, on a defined genetic background both chromosomal copies would be subject to accelerated genetic damage at the same subset of weakest origins. Under this circumstance, proximity of these sites to tumor suppressors that act preferentially in a particular cell type could account for the high penetrance of specific tumor types. In contrast, on a mixed genetic background, the weakest origins may differ between chromosomes resulting in delayed tumor onset and differences in tumor type.
Materials and methods
MEF isolation and culture
MEFs were isolated from E12.5 or E13.5 embryos resulting from a cross between 129Sv:Mcm2 wt/IRES-CreERT2 Â same mice. MEFs were cultured in Dulbecco's modified eagle medium þ 10% fetal bovine serum and used at passage 3 after isolation.
Fiber analysis DNA fiber analysis was carried out essentially as described by Jackson and Pombo (1998) and Ge et al. (2007) . Passage 3 MEFs were labeled for 10 min with CldU, washed and labeled for 10 min with IdU in the absence of HU or treated with 200 mM HU, labeled for 20 min with CldU, washed and labeled for 20 min with IdU. CldU and IdU were detected as described previously (Maslov et al., , 2007 . Images of stained fibers were obtained by fluorescence microscopy using a Â 100 emersion lens. Origins initiating during the CldU portion of the labeling protocol were identified (based on the location of IdU) and the distances between these origins was measured.
FACS
Control MEFs, MEFs treated with 1 mM CPT for 7 h, MEFs pretreated with 5 mM caffine for 40 min followed by CPT or MEFs exposed to 5, 10 and 50 mJ of UV irradiation followed by a 6 h incubation were prepared. After treatment, we harvested the cells by trypsinization, washed them with phosphate-buffered saline and fixed them in 70% ethanol at À20 1C. The following day the pellet was washed with 1% bovine serum albumin in phosphate-buffered saline and resuspended in Krishan buffer (0.1% sodium citrate, 0.02 mg/ml RnaseA, 0.2% NP-40, 0.05 mg/ml propidium iodide, 1 N HCl). FACS (FACScan flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA), FL2-A channel) was carried out after 2 h incubation in dark at room temperature.
Neurosphere analysis
Brains removed from 14.5-day-old embryos were minced in 1 ml Dulbecco's modified eagle medium/F12 (1:1) (Life Technologies Corporation, Carlsbad, CA, USA) containing L-glutamine (2 mM; Gibco), human epidermal growth factor and human fibroblast growth factor-basic (20 ng/ml each; Sigma-Aldrich, St Louis, MO, USA), B27 serum-free supplement (Gibco) and gentamicin (50 mg/ml; Gibco) followed by incubation with trypsin (0.25% trypsin/ethylenediaminetetraacetic acid) for 15 min at 37 1C. The material was then mixed with a pipette 20 times followed by incubation with 75 U DNaseI (Life Technologies Corporation) for 15 min at 37 1C. After thorough mixing with a pipette tip (15 times), we added 100 ml of a 1:333 dilution to 100 ml medium (described above) in 96-well flat bottom plates (Linbro/ Titertek; MP Biomedicals Inc., Solon, OH, USA). Two plates were set up for each embryo representing a particular genotype determined by PCR. Cultures were fed on days 2, 4, 6 and 8 by removal of 100 ml medium and addition of fresh 100 ml medium. On day 10 the total number of neurospheres corresponding to each genotype was counted, wells containing single colonies were resuspended and half of the cells were transferred to individual wells of a new 96-well plate. Plates were examined every 2-3 days,
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